Quality Assurance (QA) is the organising principle of the Taj Pharma quality system. QA operates independently of production and Quality Control, with direct authority over batch release, deviation management, change control and supplier qualification. Every batch of DEFRATAJ is released only after the Qualified Person confirms full compliance with the approved specification.
Quality System Architecture #
The Taj Pharma Pharmaceutical Quality System is designed around ICH Q10 principles and operates through a documented hierarchy: Site Quality Manual -> Standard Operating Procedures -> Work Instructions -> Batch Records. Each level is cross-referenced and version-controlled through a validated electronic Document Management System.
Independence of QA #
- QA reports directly to senior management, independent of production
- Batch release authority rests exclusively with the nominated Qualified Person (QP)
- All deviations, OOS (Out-of-Specification) results and complaints require QA sign-off
- QA approves all SOPs, specifications, validation protocols and reports
Key QA Processes #
| Process | Scope |
|---|---|
| Change Control | Formal assessment of any change to equipment, process, specification, supplier or document; classified by risk; subject to QA approval |
| Deviation Management | Root-cause analysis for all deviations; CAPA tracking; trending at Management Review |
| CAPA (Corrective & Preventive Action) | Effectiveness verification required before closure |
| Self-Inspection / Internal Audit | Annual programme covering all GMP areas; findings tracked to closure |
| Supplier Qualification | Initial audit, approved-vendor list, periodic re-qualification for all APIs and critical excipients |
| Annual Product Quality Review (APQR) | Statistical trending of CQAs per batch, per year; drives continuous improvement |
| Complaint Management | Documented investigation, trending, and pharmacovigilance interface |
| Recall Readiness | Documented recall procedure, mock recall annually |
Batch Release #
A DEFRATAJ batch is released only after:
- Batch manufacturing record review for completeness and compliance
- Review of all in-process control data against predefined limits
- Review of finished-product QC testing against specification
- Closure of any deviation / OOS investigation
- QP certification of batch release
Data Integrity - ALCOA+ #
Taj Pharma operates under ALCOA+ data-integrity principles: Attributable, Legible, Contemporaneous, Original, Accurate - plus Complete, Consistent, Enduring and Available. Laboratory and manufacturing data systems are 21 CFR Part 11 aligned, with audit trails, access controls and periodic review.
Audit Readiness #
Taj Pharma hosts national regulatory and customer audits on an ongoing basis. Audit reports, audit responses and CAPA closure evidence are maintained for inspection. For distributor and tender partners, site audits can be arranged on signing of a Confidentiality and Non-Disclosure Agreement.